Fossil Group, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Fossil Group, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,042	2,788	2,541	2,218	1,613	1,870	1,682	1,412	1,145	1,004
Cost of revenue	1,464	1,429	1,201	1,118	843	904	852	733	548	441
Gross profit	1,578	1,359	1,340	1,099	770	966	831	680	597	563
Research and development	38.6	42.8	38.2	32.4	25.9	27.2	29.1	19.4	0	0
Selling, general and administrative	1,423	1,328	1,225	1,073	835	843	824	777	639	540
Operating expenses	1,451	1,783	1,277	1,128	906	874	832	823	701	582
Operating income	127	-424	62.7	-28.4	-135	92.6	-1.47	-143	-104	-19.1
Interest expense	26.9	43.2	42.5	29.9	31.8	25.1	19.2	21.8	19	20.2
Other non-operating income	14.1	13.7	-0.04	27	-4.83	-14.5	-1.42	8.67	4.87	-10.4
Pre-tax income	114	-454	20.2	-31.3	-172	53.1	-22.1	-156	-118	-49.8
Income tax	28.7	19.8	21.1	18.7	-76	26.4	21.4	0.52	-11.8	28.1
Net income to minority interests	6.74	4.61	2.54	2.35	0.16	1.19	0.63	0.43	-3.61	0.46
Net income	78.9	-478	-3.48	-52.4	-96.1	25.4	-44.2	-157	-103	-78.3
EBITDA	222	-343	130	26.4	-92.2	122	21.9	-124	-87.9	-6.03
EPS, basic	1.64	-9.87	-0.07	-1.04	-1.88	0.49	-0.85	-3.00	-1.94	-1.45
EPS, diluted	1.63	-9.87	-0.07	-1.04	-1.88	0.48	-0.85	-3.00	-1.94	-1.45
Shares, basic (weighted)	48.1	48.5	49.2	50.2	51.1	52	51.8	52.3	53	54.1
Shares, diluted (weighted)	48.3	48.5	49.2	50.2	51.1	52.8	51.8	52.3	53	54.1

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	297	231	403	200	316	251	199	117	124	95.8
Receivables	376	367	328	290	230	255	206	188	162	145
Inventory	542	574	378	452	295	347	376	253	179	152
Other current assets	14.6	21.1	19.3	22.4	23.2	24.1	24.7	24.4	23.5	22.6
Total current assets	1,347	1,291	1,259	1,059	990	1,023	945	711	555	468
Property, plant and equipment	274	220	183	152	114	89.8	79.9	57.2	41.6	34.1
Lease right-of-use assets			0	288	227	178	157	151	121	118
Goodwill	355	0
Total assets	2,187	1,658	1,575	1,605	1,479	1,369	1,238	978	764	689
Accounts payable	164	205	170	172	178	230	191	147	158	133
Accrued liabilities	53	70.7	76.5	51.6	78.1	73.6	44.3	44.8	43.4	48.7
Deferred revenue		27.9	71.3	80.8	50.9	40.9	42	37.6	29.8	29.2
Short-term debt	26.4	2.14	126	26.2	41.6	0.55	0.34	0.48	2.17	3.99
Total current liabilities	415	509	606	559	559	536	426	342	327	302
Long-term debt	606	440	267	203	210	150	223	212	166	201
Lease liabilities			0	289	231	175	150	138	114	104
Other non-current liabilities	72.5	76.2	80.4	40.8	43.1	30.9	19.7	18.1	17.5	16.3
Total liabilities	1,171	1,077	987	1,101	1,038	903	835	726	627	602
Total debt	631	441	393	203	226	142	216	208	165	178
Paid-in capital	213	242	268	283	294	301	306	312	315	329
Retained earnings	888	410	382	300	204	229	175	18.4	-84.3	-163
Treasury stock									0	-4.53
Other comprehensive income	-95.4	-76.3	-64.7	-80.6	-58.9	-67.3	-76.3	-76.4	-82.6	-59.9
Shareholders' equity	1,006	576	586	503	439	463	406	254	149	103
Minority interests	9.2	4.81	3.09	0.79	0.94	2.13	-2.92	-2.49	-12	-16.1
Total equity	1,015	581	589	504	440	465	403	252	137	86.8
Total liabilities and equity	2,187	1,658	1,575	1,605	1,479	1,369	1,238	978	764	689
Shares outstanding	48.3	49.5	49.5	50.5	51.5	52.1	51.8	52.5	53.3	58.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	85.6	-474	-0.94	-50	-95.9	26.6	-43.5	-157	-106	-77.8
Depreciation and amortization	94.6	81	67.6	54.8	43.1	29.6	23.3	19.1	16	13.1
Stock-based compensation	31	30.4	23	15.8	11.1	9.5	8.06	5.69	2.9	2.32
Deferred income tax	-25.8	-49.4	1.7	-9.44	4.34	7.96	5.65	-3.88	-2.45	6.85
Change in receivables	-12.9	14.4	68.3	30.9	60.7	-35.5	41.6	19.9	11.7	22.3
Change in inventory	64.8	6.83	153	-78.1	169	-62.3	-46	126	58.6	34.7
Change in payables	-43	34.9	-38.4	4.86	3.5	53.9	-35.4	-42.9	14.4	-36.3
Cash from operations	210	180	248	-14.2	101	50	-111	-59.5	46.7	-57.9
Capital expenditures	-65.7	-25.5	-18	-20.9	-8.74	-10.3	-13.3	-8.53	-6.75	-2.56
Acquisitions	0	0
Cash from investing	-12.4	-24.9	-15.6	18.7	-10.6	7.11	-8.55	-9.87	4.04	22.1
Share buybacks	-7.24	-1.22	-2.86	-4.2	-0.73	-2.42	-12.4	-0.53	-0.11	-0.16
Cash from financing	-198	-202	-62.7	-208	10.8	-113	53	-13.6	-50.2	-5.01
Exchange rate effect	8.82	-19.2	9.36	0.88	15.1	-4.24	5.92	0.46	4.49	13.7
Net change in cash	8.04	-66.2	179	-203	116	-59.7	-60.5	-82.5	5.01	-27.2
Free cash flow	144	154	230	-35.1	92.5	39.7	-124	-68	39.9	-60.5
Interest paid	26.9	43.2	38.9	25.3	21.2	16.1	17.5	27.3	23.8	16.1
Income taxes paid	14.2	36.6	28.5	18	10	-16.7	5.84	20.2	-56.1	17.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $6.20 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	56.7%	Gross profit / revenue.
Operating margin	-0.6%	Operating income / revenue.
EBITDA margin	0.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-4.2%	Pre-tax income / revenue.
Net margin	-7.1%	Net income / revenue.
FCF margin	-4.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-3.8%	Cash from operations / revenue.
Return on equity (ROE)	-77.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-10.7%	Net income / average total assets.
Return on invested capital (ROIC)	-2.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	54.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.3%	Capital expenditures / revenue.
D&A / revenue	1.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-12.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-15.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-9.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-12.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-6.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-224.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-251.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-30.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-36.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-25.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-9.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-17.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-14.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.76x	Current assets / current liabilities.
Quick ratio	0.77x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.32x	(Cash + short-term investments) / current liabilities.
Debt / equity	2.26x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	31.1%	Total debt / total assets.
Liabilities / assets	88.7%	Total liabilities / total assets.
Net debt	$124.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	24.2x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	-0.20x	Operating income / interest expense.
Working capital	$189.3M	Current assets - current liabilities.
Tangible book value	$89.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.51x	Revenue / average total assets.
Fixed asset turnover	31.9x	Revenue / average property, plant and equipment.
Inventory turnover	2.40x	Cost of revenue / average inventory.
Days inventory	152 days	365 x average inventory / cost of revenue.
Receivables turnover	8.86x	Revenue / average receivables.
Days sales outstanding	41 days	365 x average receivables / revenue.
Days payables	106 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	87 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.18	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$16.69	Revenue / diluted weighted shares.
FCF per share	-$0.70	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.64	Cash from operations / diluted weighted shares.
Book value per share	$1.52	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$1.52	Tangible book value / shares outstanding.
Cash per share	$1.34	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$366.7M	Share price x shares outstanding.
Enterprise value	$490.7M	Market cap + total debt - cash - short-term investments.
P/S	0.37x	Market cap / revenue.
P/B	4.08x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	4.08x	Market cap / tangible book value, when positive.
EV/Sales	0.50x	Enterprise value / revenue.
EV/EBITDA	95.9x	Enterprise value / EBITDA, when both are positive.
FCF yield	-11.2%	Free cash flow / market cap.
Earnings yield	-19.1%	Net income / market cap (the inverse of P/E).

What was Fossil Group, Inc.'s revenue in fiscal 2025?

Fossil Group, Inc. reported revenue of $1.00B for fiscal 2025, 12.3% lower than the year before.

Was Fossil Group, Inc. profitable in fiscal 2025?

No. It reported a net loss of $78.3M.

How much free cash flow did Fossil Group, Inc. generate in fiscal 2025?

Cash from operations of $57.9M minus capital expenditures of $2.6M left free cash flow of -$60.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Fossil Group, Inc.